Université de Versailles Saint-Quentin-en-Yvelines, EA 4497, Faculté de Médecine, PIFO, France.
Clin Nutr. 2013 Jun;32(3):391-5. doi: 10.1016/j.clnu.2012.08.020. Epub 2012 Aug 31.
BACKGROUND & AIMS: Aminotransferase abnormalities have been reported in malnourished patients with anorexia nervosa (AN). The aim of this study was to identify prevalence and risk factors of hyperaminotransferasemia in an adult cohort of AN patients and to describe evolution during nutritional rehabilitation with enteral nutrition for a period of 4 weeks.
Retrospective study of all consecutive malnourished (BMI <16) AN adult patients, without previous liver diseases or hepatotoxic drugs or alcohol consumption, hospitalized for enteral nutrition in a single center between 1998 and 2008. Hypertransaminasemia was defined by an increase in AST and (or) ALT >2N.
In all, 126 AN patients (117 W, 9 M), age 30 ± 10.8 years, were included. At admission, 54 (43%) patients presented hypertransaminasemia. In univariate analysis, risk factors for hypertransaminasemia were: lower BMI (11.2 ± 2 vs. 13 ± 2, p < 0.0001) and age (28 ± 9 vs. 32 ± 12, p < 0.05), male sex (p < 0.05) and the pure restrictive form (p = 0.07). In multivariate analysis only BMI, at a threshold of 12, remained significant [OR 3.7, CI: 95% 2.24-5.2]. Normalization of aminotransferases at the end of week 4 of enteral nutrition was obtained in 96%. Only 2/54 patients (4%) presented a worsening of aminotransferases during the refeeding period, including one that died of liver failure. None of the patients without hypertransaminasemia admission presented a subsequent elevation. At the end of the 4-week refeeding period, the increase in BMI was greater in patients without hypertransaminasemia than in those with it (2.0 ± 0.8 vs. 1.5 ± 1.0, p < 0.0001).
Elevated transaminases is common in severe malnourished AN patients. Four risk factors were identified: young age, low BMI (the only independent factor in multivariate analysis), the pure restrictive form of the disease and male sex. After 4 weeks of enteral nutrition the evolution is in most cases favourable, albeit with a lower increase in BMI, but can be severe. The long-term evolution remains to be determined.
已有研究报道神经性厌食症(AN)患者存在营养不良伴氨基转移酶异常。本研究旨在明确成人 AN 患者中高氨基转移酶血症的发生率和相关危险因素,并描述采用肠内营养治疗 4 周期间的演变情况。
回顾性分析 1998 年至 2008 年期间于我院因营养不良(BMI<16)接受肠内营养治疗的所有连续 AN 成年患者,排除既往有肝脏疾病、肝毒性药物或酒精摄入史的患者。氨基转移酶升高定义为天门冬氨酸氨基转移酶(AST)和(或)丙氨酸氨基转移酶(ALT)升高超过 2 倍正常值上限。
共纳入 126 例 AN 患者(女性 117 例,男性 9 例),年龄 30±10.8 岁。入院时,54 例(43%)患者存在氨基转移酶升高。单因素分析显示,高氨基转移酶血症的危险因素为:较低的 BMI(11.2±2 与 13±2,p<0.0001)和年龄(28±9 与 32±12,p<0.05)、男性(p<0.05)和单纯限制型(p=0.07)。多因素分析仅显示 BMI 具有显著意义(切点为 12,OR 3.7,95%CI:2.24-5.2)。肠内营养治疗 4 周结束时,96%的患者氨基转移酶恢复正常。仅有 2/54 例(4%)患者在喂养期间出现氨基转移酶恶化,其中 1 例死于肝功能衰竭。无氨基转移酶升高的患者在随访期间均未出现氨基转移酶升高。在 4 周喂养结束时,无高氨基转移酶血症患者的 BMI 增加值大于有高氨基转移酶血症患者(2.0±0.8 与 1.5±1.0,p<0.0001)。
严重营养不良的 AN 患者中,氨基转移酶升高较为常见。共确定了 4 个危险因素:年龄较小、BMI 较低(多因素分析中唯一的独立因素)、单纯限制型疾病和男性。经 4 周肠内营养治疗后,大多数患者病情好转,尽管 BMI 增加值较低,但也可能病情严重。长期演变情况尚待确定。